ROBOTICS & AUTOMATION
Empowering Progress
Up to 25% off Essentials Robotics and Automation titles
Cardio-oncology, An Issue of Cardiology Clinics
- 1st Edition, Volume 43-1 - November 21, 2024
- Editors: Eric H. Yang, Ashley F. Stein-Merlob
- Language: English
- Hardback ISBN:9 7 8 - 0 - 4 4 3 - 2 4 6 8 4 - 5
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 2 4 6 8 5 - 2
In this issue of Cardiology Clinics, guest editors Drs. Eric H. Yang and Ashley F. Stein-Merlob bring their considerable expertise to the topic of Cardio-oncology. Top experts d… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteIn this issue of Cardiology Clinics, guest editors Drs. Eric H. Yang and Ashley F. Stein-Merlob bring their considerable expertise to the topic of Cardio-oncology. Top experts discuss key topics such as anthracycline-induced cardiotoxicity; cardiac complications of immunotherapy: immune checkpoint inhibitors and CAR T cell therapy; advances in diagnosis and treatment of amyloid cardiomyopathy; guidelines in cardio-oncology; and more.
- Contains 18 relevant, practice-oriented topics including permissive cardiotoxicity; advances in imaging of cardiotoxicity; management of cancer therapy-related hypertension; cardiac complications of radiation therapy; health disparities in cardio-oncology; and more.
- Provides in-depth clinical reviews on cardio-oncology, offering actionable insights for clinical practice.
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Cardiology
- Cover image
- Title page
- Table of Contents
- Copyright
- Contributors
- Forthcoming Issues
- Preface
- Cardiovascular Risk Assessment and Prevention in Cardio-Oncology: Beyond Traditional Risk Factors
- Key points
- Introduction
- Emerging risk factors
- Access to care
- Neighborhood
- Financial toxicity
- Health insurance coverage
- Environmental factors and air quality
- Microbiome
- Novel methods of risk factor detection and prevention
- Multi-omics approach
- Advanced imaging studies and radiomics
- Machine learning and large language models
- Summary and concluding remarks
- Clinics care points
- Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Health
- Key points
- Introduction
- Clonal hematopoiesis of indeterminate potential
- Risk factors for clonal hematopoiesis of indeterminate potential
- Clinical associations
- Mechanisms of cardiovascular disease
- Therapeutic strategies
- Summary
- Clinics care points
- Unique Challenges of Adult Congenital Heart Disease in CardioOncology
- Key points
- Introduction
- Syndromes associated with congenital heart disease and increased risk of cancer
- Patients with complex single ventricle physiology and risk of hepatocellular carcinoma
- Risk of thymectomy and cancer
- Radiation exposure and cancer
- Inadequate cancer screening in adult congenital heart disease patients
- Cancer treatment in adult congenital heart disease patients
- Summary
- Clinics care points
- Classes of Antineoplastic Agents Associated with Increased Risk of Cancer Therapy-associated Hypertension and Management Strategies
- Key points
- Introduction
- Why does cancer therapy-associated hypertension matter?
- Classes of cancer therapies associated with hypertension
- Diagnosis and management of cancer therapy-related hypertension
- Summary
- Clinics care points
- Arrhythmia Challenges in Cardio-Oncology: High-Risk Therapies, Management, and Anticoagulation
- Key points
- Introduction
- Atrial fibrillation
- Ventricular arrhythmias
- Bradyarrhythmia and blocks
- Summary
- Clinics care points
- Ischemic Heart Disease in the Cancer Population: Trends, Outcomes, Epidemiology, and Challenges in Diagnosis and Treatment
- Key points
- Introduction
- Discussion
- Summary
- Clinics care points
- Cardiovascular Health in Breast Cancer: Survivorship Care
- Key points
- Introduction
- The team
- Education of patients
- New breast cancer therapies
- Radiation therapy
- Promoting healthy behaviors
- Future direction
- Clinics care points
- Cardiovascular Risk in Prostate Cancer
- Key points
- Introduction
- Epidemiology of cardiovascular disease in patients with prostate cancer
- Mechanisms underlying cardiovascular disease in prostate cancer
- Addressing cardiovascular risk in patients with prostate cancer
- Management of severe cardiovascular disease in patients with metastatic prostate cancer
- Summary
- Clinics care points
- Evolving Strategies in Cardiac Amyloidosis: From Mechanistic Discoveries to Diagnostic and Therapeutic Advances
- Key points
- Introduction
- Epidemiology of cardiac amyloidosis
- Pathophysiology of cardiac amyloidosis
- Diagnosis of cardiac amyloidosis
- Treatment of ATTR-cardiomyopathy
- Treatment of AL-cardiomyopathy
- Racial, gender, and socioeconomic disparities in cardiac amyloidosis
- Summary
- Clinics care points
- Cardiotoxicity of Anthracyclines
- Key points
- Introduction
- Clinical manifestations
- Pathogenesis
- Incidence
- Risk assessment
- Pretreatment imaging
- Preventive strategies
- Surveillance and diagnosis
- Management of anthracycline cardiotoxicity
- Long-term surveillance in survivors of adult cancers
- Adult survivors of childhood cancer
- Future directions
- Clinics care points
- Cardiac Complications of Radiation Therapy
- Key points
- Introduction
- Summary of radiation principles
- Radiation-induced cardiovascular disease: clinical trials and cohort studies
- Pathophysiology of radiation-induced cardiac toxicity
- Risk factors of radiation-induced cardiotoxicity
- Screening for radiation-induced cardiotoxicity
- Management of radiation-induced cardiotoxicities
- Novel therapeutic applications of radiation therapy in cardiac conditions
- Summary
- Clinics care points
- Cardiac Complications of Immune Checkpoint Inhibitors and Chimeric Antigen Receptor T Cell Therapy
- Key points
- Introduction
- Mechanisms of cardiotoxicity
- Epidemiology, manifestations, and clinical features
- Diagnostic studies
- Management
- Prognosis and surveillance
- Impact of cardiometabolic, socio-economic and environmental factors on immunotherapy induced cardiotoxicity
- Future directions in the management of cardiac immune-related adverse events
- Summary
- Clinics care points
- Cardio-oncology Drug Interactions: A Primer for Clinicians on Select Cardiotoxic Oncologic Therapies
- Key points
- Introduction
- Discussion
- Summary
- Clinics care points
- Cardio-Oncology Program Building: A Practical Guide
- Key points
- Core people and teams: the building blocks of a cardio-oncology program
- Key services, workflow, and integration within health care system
- Strategies for building a successful cardio-oncology program
- Clinics care points
- No. of pages: 240
- Language: English
- Edition: 1
- Volume: 43-1
- Published: November 21, 2024
- Imprint: Elsevier
- Hardback ISBN: 9780443246845
- eBook ISBN: 9780443246852
EY
Eric H. Yang
Affiliations and expertise
Associate Clinical Professor of Medicine, Director, UCLA Cardio-Oncology Program,Associate Program Director, UCLA/Olive View/West LA VA Cardiovascular Diseases Fellowship, Division of Cardiology, Department of Medicine, University of California, Los AngelesAS
Ashley F. Stein-Merlob
Affiliations and expertise
Division of Cardiology, Department of Medicine, University of California at Los Angeles, Los Angeles, CA, USA